Fig. 4From: Complete response to orally administered melphalan in malignant pleural effusion from an occult female genital organ primary neoplasm with BRCA1/2 mutations: a case reportChest X-ray films before indwelling drainage plus melphalan therapy (a, Feb. 14, 2017) and 2 months after completing six courses of melphalan treatment (b, Oct. 26, 2017)Back to article page